🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

40 results for “Atrium” Clear

  1. GENTAMICINE PANPHARMA 80 mg, solution injectable, Gentamicin Placebo, Metronidazole Biogaran 500 mg Placebo, Natriumchlorid-Lösung 0,9 % Deltamedica, Injektionslösung, METRONIDAZOLE BIOGARAN 500 mg, comprimé pelliculé

    Pari Pharma GmbH

    Acute mesenteric ischemia

    phase 3 small molecule active

    1 trial

  2. Insulatard 100 international units/ml suspension for injection in vial., Natriumchloride 0,9% oplossing voor injectie

    Disc Medicine

    Delirium

    phase 3 small molecule active

    1 trial

  3. Isotone Natriumchloridlösung 0,9 % Braun Injektionslösung, JNJ-80202135, JNJ-80202135

    Janssen-Cilag International N.V.

    Warm Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    1 trial

  4. Natriumklorid B. Braun 9 mg/ml infusjonsvæske, oppløsning, BOTOX 50 Allergan-enheter Pulver til injeksjonsvæske, oppløsning

    Ology Bioservices Ireland LTD

    Chronic cluster headache

    phase 3 small molecule active

    1 trial

  5. Natriumklorid Braun 9 mg/ml spädningsvätska för parenteral användning, COLECALCIFEROL , GRAZAX 75 000 SQ-T frystorkad sublingual tablett, Alutard SQ Timotej, 10 000 SQ-E/ml, injektionsvätska, suspension

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Allergisk Rinit

    phase 3 small molecule active

    1 trial

  6. PGET

    Atrium Therapeutics

    Osteoarthritis

    phase 3 other terminated

    1 trial

  7. Phlebotomy

    Atrium Therapeutics

    Hemochromatosis

    phase 3 other completed

    1 trial

  8. Phlebotomy and erythrocytapheresis

    Atrium Therapeutics

    Hereditary Hemochromatosis

    phase 3 other active

    1 trial

  9. Ropivacaine HCL

    Atrium Therapeutics

    Renal Carcinoma

    phase 3 small molecule active

    1 trial

  10. Wobenzym® N

    Atrium Therapeutics

    Knee Osteoarthritis

    phase 3 other terminated

    1 trial

  11. eythrocytapheresis

    Atrium Therapeutics

    Pre Operative Autologous Donation

    phase 3 other completed

    1 trial

  12. AUR200, Isotone Natriumchloridlösung 0,9 % Braun Injektionslösung

    Aurinia Pharmaceuticals

    Generalized Myasthenia Gravis

    phase 2 small molecule active

    1 trial

  13. Actrapid 100 international units/ml solution for injection in vial, Natriumklorid Fresenius Kabi, 9 mg/ml, infusionsvätska, lösning, SODIUM CHLORIDE, Natriumklorid Fresenius Kabi 9 mg/ml, spädningsvätska för parenteral användning, Albumin Baxalta 200 g/l infusionsvätska, lösning, Glucos Fresenius Kabi 200 mg/ml infusionsvätska, lösning, A24110He

    Pharma Mar S.A.

    Moderate to severe hypertriglyceridemia

    phase 2 small molecule active

    1 trial

  14. Carboplatin

    Atrium Therapeutics

    Lung Cancer Stage II

    phase 2 small molecule active

    1 trial

  15. Diclofenac

    Atrium Therapeutics

    Wobenzym

    phase 2 small molecule completed

    1 trial

  16. Elotuzumab

    Atrium Therapeutics

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial

  17. Low-dose ASA

    Atrium Therapeutics

    Germ Cell Tumor

    phase 2 small molecule active

    1 trial

  18. Metformin Hydrochloride ER

    Atrium Therapeutics

    Sarcoma Metastatic

    phase 2 small molecule active

    1 trial

  19. Natriumthiosulfat 25%

    Disc Medicine

    Raynaud’s phenomenon

    phase 2 small molecule active

    1 trial

  20. Nivolumab

    Atrium Therapeutics

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  21. Olutasidenib

    Atrium Therapeutics

    IDH1 Mutation

    phase 2 small molecule active

    1 trial

  22. Vaccine

    Atrium Therapeutics

    Pediatric Cancer

    phase 2 mab active

    1 trial

  23. anastrozole

    Atrium Therapeutics

    Female Breast Carcinoma

    phase 2 small molecule active

    1 trial

  24. 15O-WATER, Natriumklorid Fresenius Kabi, 9 mg/ml, infusionsvätska, lösning, AZD3427, Dopamin Fresenius 50 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung, Placebo for AZD3427 or AZD3427 diluent

    AstraZeneca AB

    Heart failure with reduced ejection fraction, Renal impairment

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources